Novel crystals and process of making 5-({[2-amino-3-(4-carbamoyl-2,6-dimeth ylphenyl)-propionyl]-[1-(4-phenyl-1h-imid azol2-yl)-ethyl]-amino}-methyl)-2-methoxybenzoic acid

Details for Australian Patent Application No. 2008275270 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Teleha, Christopher Allan; Villani, Frank J.; Anzalone, Luigi; Feibush, Penina; Fegely, Barry

Agent Shelston IP

Pub. Number AU-A-2008275270

PCT Pub. Number WO2009/009480

Priority 60/948,584 09.07.07 US

Filing date 7 July 2008

Wipo publication date 15 January 2009

International Classifications

A61K 31/4164 (2006.01) - 1,3-Diazoles

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

C07D 233/64 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

Event Publications

28 January 2010 PCT application entered the National Phase

  PCT publication WO2009/009480 Priority application(s): WO2009/009480

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008275278-Antibody formulations

2008275267-Pulling roll for the production of sheet glass